New drug cocktail shows promise against tough cancers
NCT ID NCT06783647
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called LBL-024 combined with other medicines in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the combination can shrink tumors or stop them from growing. About 230 adults aged 18-75 will take part, and the study will monitor side effects and how long any benefits last.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOUR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Guilin Medical University
RECRUITINGGuilin, Guangxi, 541001, China
-
Anhui Provincial Cancer Hospital
RECRUITINGHefei, Anhui, 230031, China
-
Beijing Cancer Hospital
RECRUITINGBeijing, Beijing Municipality, 100142, China
-
Beijing Chest Hospital,Capital Medical University
RECRUITINGBeijing, Beijing Municipality, 101100, China
-
First Hospital of Shanxi Medical University
RECRUITINGTaiyuan, Shanxi, 030012, China
-
Fujian Cancer Hospital
RECRUITINGFuzhou, Fujian, 350014, China
-
Ganzhou People's Hospital
RECRUITINGGanzhou, Jiangxi, 341006, China
-
Guangxi Medical University Cancer Hospital
RECRUITINGNanning, Guangxi, 530021, China
-
Harbin Medical University Cancer Hospital
RECRUITINGHarbin, Heilongjiang, 150081, China
-
Henan Cancer Hospital
RECRUITINGZhengzhou, Henan, 450003, China
-
Jiangxi Cancer Hospital
RECRUITINGNanchang, Jiangxi, 330029, China
-
Liaoning Cancer Hospital and Institute
RECRUITINGShenyang, Liaoning, 110167, China
-
Mianyang Central Hospital
RECRUITINGMianyang, Sichuan, 621000, China
-
Shandong Cancer Hospital
RECRUITINGJinan, Shandong, 250117, China
-
Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, 610072, China
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510060, China
-
Taizhou Hospital of Zhejiang Province
RECRUITINGTaizhou, Zhejiang, 317000, China
-
The First Affiliated Hospital of Guangdong Pharmaceutical University
RECRUITINGGuangzhou, Guangdong, 510062, China
-
The First Affiliated Hospital of Henan University of Science & Technology
RECRUITINGLuoyang, Henan, 471023, China
-
The First Affiliated Hospital of Xiamen University
RECRUITINGXiamen, Fujian, 361102, China
-
The Second Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, 410011, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430022, China
-
Xiangyang Central Hospital
RECRUITINGXiangyang, Hubei, 441106, China
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, Zhejiang, 310022, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?
- Can a targeted pill outsmart a tough lung cancer mutation?
- Can a PET scan reveal hidden heart harm from lung cancer treatment?